Effects of PTH on osteocyte function

Teresita Bellido, Vaibhav Saini, Paola Divieti Pajevic

Research output: Contribution to journalArticle

84 Citations (Scopus)

Abstract

Osteocytes are ideally positioned to detect and respond to mechanical and hormonal stimuli and to coordinate the function of osteoblasts and osteoclasts. However, evidence supporting the involvement of osteocytes in specific aspects of skeletal biology has been limited mainly due to the lack of suitable experimental approaches. Few crucial advances in the field in the past several years have markedly increased our understanding of the function of osteocytes. The development of osteocytic cell lines initiated a plethora of in vitro studies that have provided insights into the unique biology of osteocytes and continue to generate novel hypotheses. Genetic approaches using promoter fragments that direct gene expression to osteocytes allowed the generation of mice with gain or loss of function of particular genes revealing their role in osteocyte function. Furthermore, evidence that Sost/sclerostin is expressed primarily in osteocytes and inhibits bone formation by osteoblasts, fueled research attempting to identify regulators of this gene as well as other osteocyte products that impact the function of osteoblasts and osteoclasts. The discovery that parathyroid hormone (PTH), a central regulator of bone homeostasis, inhibits sclerostin expression generated a cascade of studies that revealed that osteocytes are crucial target cells of the actions of PTH. This review highlights these investigations and discusses their significance for advancing our understanding of the mechanisms by which osteocytes regulate bone homeostasis and for developing therapies for bone diseases targeting osteocytes. This article is part of a Special Issue entitled "The Osteocyte".

Original languageEnglish
Pages (from-to)250-257
Number of pages8
JournalBone
Volume54
Issue number2
DOIs
StatePublished - Jun 2013

Fingerprint

Osteocytes
Parathyroid Hormone
Osteoblasts
Osteoclasts
Homeostasis
Bone and Bones
Bone Diseases
Regulator Genes
Osteogenesis

Keywords

  • FGF23
  • Osteocyte
  • PTH
  • PTH receptor
  • RANKL
  • Sclerostin

ASJC Scopus subject areas

  • Physiology
  • Endocrinology, Diabetes and Metabolism
  • Histology

Cite this

Effects of PTH on osteocyte function. / Bellido, Teresita; Saini, Vaibhav; Pajevic, Paola Divieti.

In: Bone, Vol. 54, No. 2, 06.2013, p. 250-257.

Research output: Contribution to journalArticle

Bellido, T, Saini, V & Pajevic, PD 2013, 'Effects of PTH on osteocyte function', Bone, vol. 54, no. 2, pp. 250-257. https://doi.org/10.1016/j.bone.2012.09.016
Bellido, Teresita ; Saini, Vaibhav ; Pajevic, Paola Divieti. / Effects of PTH on osteocyte function. In: Bone. 2013 ; Vol. 54, No. 2. pp. 250-257.
@article{5e80738528f04923b0207d51af96d971,
title = "Effects of PTH on osteocyte function",
abstract = "Osteocytes are ideally positioned to detect and respond to mechanical and hormonal stimuli and to coordinate the function of osteoblasts and osteoclasts. However, evidence supporting the involvement of osteocytes in specific aspects of skeletal biology has been limited mainly due to the lack of suitable experimental approaches. Few crucial advances in the field in the past several years have markedly increased our understanding of the function of osteocytes. The development of osteocytic cell lines initiated a plethora of in vitro studies that have provided insights into the unique biology of osteocytes and continue to generate novel hypotheses. Genetic approaches using promoter fragments that direct gene expression to osteocytes allowed the generation of mice with gain or loss of function of particular genes revealing their role in osteocyte function. Furthermore, evidence that Sost/sclerostin is expressed primarily in osteocytes and inhibits bone formation by osteoblasts, fueled research attempting to identify regulators of this gene as well as other osteocyte products that impact the function of osteoblasts and osteoclasts. The discovery that parathyroid hormone (PTH), a central regulator of bone homeostasis, inhibits sclerostin expression generated a cascade of studies that revealed that osteocytes are crucial target cells of the actions of PTH. This review highlights these investigations and discusses their significance for advancing our understanding of the mechanisms by which osteocytes regulate bone homeostasis and for developing therapies for bone diseases targeting osteocytes. This article is part of a Special Issue entitled {"}The Osteocyte{"}.",
keywords = "FGF23, Osteocyte, PTH, PTH receptor, RANKL, Sclerostin",
author = "Teresita Bellido and Vaibhav Saini and Pajevic, {Paola Divieti}",
year = "2013",
month = "6",
doi = "10.1016/j.bone.2012.09.016",
language = "English",
volume = "54",
pages = "250--257",
journal = "Bone",
issn = "8756-3282",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Effects of PTH on osteocyte function

AU - Bellido, Teresita

AU - Saini, Vaibhav

AU - Pajevic, Paola Divieti

PY - 2013/6

Y1 - 2013/6

N2 - Osteocytes are ideally positioned to detect and respond to mechanical and hormonal stimuli and to coordinate the function of osteoblasts and osteoclasts. However, evidence supporting the involvement of osteocytes in specific aspects of skeletal biology has been limited mainly due to the lack of suitable experimental approaches. Few crucial advances in the field in the past several years have markedly increased our understanding of the function of osteocytes. The development of osteocytic cell lines initiated a plethora of in vitro studies that have provided insights into the unique biology of osteocytes and continue to generate novel hypotheses. Genetic approaches using promoter fragments that direct gene expression to osteocytes allowed the generation of mice with gain or loss of function of particular genes revealing their role in osteocyte function. Furthermore, evidence that Sost/sclerostin is expressed primarily in osteocytes and inhibits bone formation by osteoblasts, fueled research attempting to identify regulators of this gene as well as other osteocyte products that impact the function of osteoblasts and osteoclasts. The discovery that parathyroid hormone (PTH), a central regulator of bone homeostasis, inhibits sclerostin expression generated a cascade of studies that revealed that osteocytes are crucial target cells of the actions of PTH. This review highlights these investigations and discusses their significance for advancing our understanding of the mechanisms by which osteocytes regulate bone homeostasis and for developing therapies for bone diseases targeting osteocytes. This article is part of a Special Issue entitled "The Osteocyte".

AB - Osteocytes are ideally positioned to detect and respond to mechanical and hormonal stimuli and to coordinate the function of osteoblasts and osteoclasts. However, evidence supporting the involvement of osteocytes in specific aspects of skeletal biology has been limited mainly due to the lack of suitable experimental approaches. Few crucial advances in the field in the past several years have markedly increased our understanding of the function of osteocytes. The development of osteocytic cell lines initiated a plethora of in vitro studies that have provided insights into the unique biology of osteocytes and continue to generate novel hypotheses. Genetic approaches using promoter fragments that direct gene expression to osteocytes allowed the generation of mice with gain or loss of function of particular genes revealing their role in osteocyte function. Furthermore, evidence that Sost/sclerostin is expressed primarily in osteocytes and inhibits bone formation by osteoblasts, fueled research attempting to identify regulators of this gene as well as other osteocyte products that impact the function of osteoblasts and osteoclasts. The discovery that parathyroid hormone (PTH), a central regulator of bone homeostasis, inhibits sclerostin expression generated a cascade of studies that revealed that osteocytes are crucial target cells of the actions of PTH. This review highlights these investigations and discusses their significance for advancing our understanding of the mechanisms by which osteocytes regulate bone homeostasis and for developing therapies for bone diseases targeting osteocytes. This article is part of a Special Issue entitled "The Osteocyte".

KW - FGF23

KW - Osteocyte

KW - PTH

KW - PTH receptor

KW - RANKL

KW - Sclerostin

UR - http://www.scopus.com/inward/record.url?scp=84875850665&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875850665&partnerID=8YFLogxK

U2 - 10.1016/j.bone.2012.09.016

DO - 10.1016/j.bone.2012.09.016

M3 - Article

C2 - 23017659

AN - SCOPUS:84875850665

VL - 54

SP - 250

EP - 257

JO - Bone

JF - Bone

SN - 8756-3282

IS - 2

ER -